Treatment of Drug-Susceptible Tuberculosis-Reference-Cited by-同舟云学术

Treatment of Drug-Susceptible Tuberculosis

Published:2019-12 Issue:4 Volume:40 Page:763-774
ISSN:0272-5231
Container-title:Clinics in Chest Medicine
language:en
Short-container-title:Clinics in Chest Medicine

Author:

Zha Beth Shoshana,Nahid Payam

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pulmonary and Respiratory Medicine

Reference88 articles.

1. Delays to treatment initiation is associated with tuberculosis treatment outcomes among patients on directly observed treatment short course in Southwest Ethiopia: a follow-up study;Asres;BMC Pulm Med,2018

2. Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study;Virenfeldt;BMJ Open,2014

3. Executive summary: official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis;Nahid;Clin Infect Dis,2016

4. Use of the amplified Mycobacterium tuberculosis direct test in a public health laboratory: test performance and impact on clinical care;Guerra;Chest,2007

5. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis;Centers for Disease Control and Prevention (CDC);MMWR Morb Mortal Wkly Rep,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quabodepistat in combination with delamanid and bedaquiline in participants with drug-susceptible pulmonary tuberculosis: protocol for a multicenter, phase 2b/c, open-label, randomized, dose-finding trial to evaluate safety and efficacy;Trials;2024-01-19

2. A Retroactive Study on Factors Influencing the Efficacy of Treatment for Tuberculosis Patients with HIV: based on the data from 2010 to 2020 in Shanghai, China;2023-12-29

3. Lipophilic AIEgens as the “Trojan Horse” with Discrepant Efficacy in Tracking and Treatment of Mycobacterial Infection;Advanced Healthcare Materials;2023-11-23

4. Unsuccessful treatment outcome and associated risk factors. A prospective study of DR-TB patients from a high burden country, Pakistan;PLOS ONE;2023-08-10

5. Relationship between common telomere length‐related genetic variations, telomere length, and risk of antituberculosis drug‐induced hepatotoxicity in Chinese Han population: As assessed for causality using the updated Roussel Uclaf Causality Assessment Method;Fundamental & Clinical Pharmacology;2023-03-07